Valeant Pharmaceuticals Intl Inc: Pearson Out, Ackman In, Stock UpMark Melin
With trading halted this morning for news on Valeant Pharmaceuticals near 9AM EST, that news came in strong this morning as the embattled firm announced that CEO J. Michael Pearson was stepping down, its best known investor, William Ackman of Pershing Square Management, was being installed on the board of directors, the firm acknowledged “material weaknesses” in its financial . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email firstname.lastname@example.org or click chat.